MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: BioPharmaceuticals _ Biotechnology, Genomics, Genetics, Bioinformatics, Biomanufacturing & Personalized Medicine
*Biotechnology: Key Issues
*Key Terms: Biotechnology
DNA
Parents
*Key Terms: Biotechnology
BioTechnology
Children
- molecular biology services, including plasmid construction, DNA purification, DNA sequencing, transfections, and expression an
* DNA and RNA Extraction
* DNA and RNA QC Services
* Focused DNA Methylation Analysis
*Architects: Biotechnology_DNA, RNA, RNAi, siRNA & mRNA
*Backed by $266 million & has begun selling a system designed to significantly cut the cost and boost the speed of DNA sequencing
*Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
*By tracking RNA biomarkers, Geneoscopy thinks it can identify changes that occur downstream of cancer-causing DNA mutations, enabling it to detect tumors early.
*Development-stage medical device company focused on DNA sequencing via an electronic, label-free analysis of single molecule platform
*DNA based therapeutics
*DNA-sequencing service
*Genetic testing and information company which processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients.
*Genomics Definition: Study of the genome, i.e. the whole hereditary information of an organism that is encoded in the DNA (or,
*Integrated DNA Technologies, Inc. (IDT)
*It has developed a proprietary platform that is designed to systematically and efficiently analyse unexploited region of DNA in human disease tissue to identify and drug novel targets linked to genomically defined patient populations.
*It is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases using DNA-directed RNA interference technology.
*It takes advantage of the growing ability of scientists to design and print DNA on demand — the field now known as synthetic biology.
*Its technologies are used in DNA sequencing, diagnostics, drug development, biomolecular interaction, ion channel screening, and defense applications.
*Key People: DNANexus
*Key People: DNAtriX
*New generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the skin
*Offers a highly efficient, non-viral, non-DNA based method to recapitulate human physiology for commercial scale drug discovery and therapeutic use
*Pioneers: Biotechnology_DNA
*Proprietary “zinc-finger protein technology,” which is designed to edit specific DNA sequences inside a cell, to, say, turn off a disease activity.
*Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue.
*SOPHiA GENETICS is building Data-Driven Medicine with DNA sequencing, genomic data analysis, and developing and validating accurate algorithms, using world-leading machine learning technology.
*Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.
*The company offers BASE technology, a system for DNA sequencing that employs nanopores to process, identify, and record DNA bases in sequence.
*The targeted manipulation of genomic DNA has a broad range of applications including the correction of genetic disorders, the treatment of viral infections, the improvement of crops, and the engineering of cell lines for research or biomanufacturing.
*The technology is based on the production of custom-made DNA-cutting enzymes called "DNE meganucleases".
*The test looks for severe fetal genetic abnormalities by testing fetal DNA found in maternal blood
*Twist Bioscience manufactures synthetic DNA for clients in the biotechnology industry.
*Twist Bioscience, whose disruptive platform manufactures synthetic DNA by “writing” DNA on a silicon chip, joined Illumina, Microsoft, and data storage giant Western Digital to co-lead the DNA Data Storage Alliance.
*Use of PCR technology to obtain specimens of circulating tumor DNA from peripheral blood.
*Using state-of-the-art protein engineering techniques, Precision BioSciences alters the genetic sequence of a natural genome-editing meganuclease to create a custom meganuclease with unique DNA-recognition and cleavage properties.
*We are dedicated to realizing the exceptional advantages of Better DNA™
100,00 DNA profiles
2010: Democratizing DNA Sequencing (2010)
2010: Life Tech, In Competitive Frenzy for Cheap DNA Sequencing, Buys Ion Torrent for $375M (2010)
2011: DNA Sequencing Caught in Deluge of Data (2011)
2011: DNA testing company Orchid to be acquired by LabCorp for $85M (2011)
2011: Gene Security Network Completes Funding to Expand into New DNA Testing Markets-$12M Series C Led by Sequoia Capital (2011)
2011: OraSure Technologies Inc Acquires DNA Genotek for$53 million (2011)
2011: Pacific Biosciences, Cycle Computing partner for DNA analysis in the cloud - Silicon Valley (2011)
2011: PerkinElmer Acquires Geospiza, Beefing Up Software for DNA Analysis (2011)
2011: PerkinElmer Launches Next Generation DNA Sequencing and Analysis Services (2011)
2012: Ion Proton DNA Sequencer Decodes a Human Genome in One Day for $1,000 (2012)
2012: Long Fragment Read Technology for More Complete and Accurate DNA Sequencing (2012)
2012: Oxford Nanopore Unveils Tiny DNA Sequencing Device (2012)
2012: Synthetic Genomics Inc and Integrated DNA Technologies Sign Agreement to Commercialize Synthetic Gene Products Using SGI Technology (2012)
2013: Google-backed DNAnexus gets $15M Series C to be a hub for all that sequencing data_ medcitynews (2013)
2013: What Does This $14 Billion Deal Mean For The Future Of DNA Sequencing? (2013)
2014: Human Longevity Inc. will use machines from Illumina Inc. (ILMN), which has a stake in the company, to decode the DNA of people from children to centenarians
2014: In August, Exact Sciences was granted PMA approval for Cologard, the first and only FDA-approved DNA test for colorectal cancer.
2014: News Highlights:DARPA Awards $12.2M to Study DNA mAbs for Infectious Disease
2014: NIH awards $14.5 million to research groups studying newest DNA sequencing techniques
2014: Venter Starts DNA-Scanning Company to Boost Longevity
2015: DNA Data Added to EHRs_federaltelemedicine
2016: Inovio Pharmaceuticals (NASDAQ:INO) was up better than five percent on the day as the FDA has approved the start of a Phase I clinical trial to evaluate its Zika DNA vaccine candidate in 40 healthy volunteers.
2016: ProNAi Therapeutics Inc. (NASDAQ:DNAI) - 53% discount to net cash
2017: 23andMe Is Mining Your DNA For The Next Big Drug. It Just Raised $250 Million.
2017: U.S. Army_Brand Name or Equal to DNA Reference Specimen Collection Materials and Supplies
2017: VA_66--Automated QC Analysis for DNA/RNA Instrument Agilent 400 TapeStation System Southeast Louisiana Veterans Healthcare System New Orleans
2018: Nebula Genomics, with free DNA sequencing, opens for business
2019: FDA_Sequencing (16) Genomic DNA samples from cancer patients
2019: Genetic Testing Companies Take DNA Tests To A Whole New Level
2019: Grail nets FDA breakthrough designation, turns eye toward DNA methylation for early cancer detection
2019: Invitae to buy DNA-counseling chatbot developer Clear Genetics for $50M
2019: NHLBI_DNA & RNA Sequencing Services Requested
2019: NIH_NIA_DNA and RNA Sequencing of parental iPSC cell lines
2019: Pentagon advises troops to not use consumer DNA kits, citing security risks
2019: Utah's Intermountain Healthcare starts US's largest DNA map project
2020: A New Way Of Making DNA Is About To Revolutionize The Biotech Industry
2020: Ancestry to lay off 6% of workforce because of a slowdown in the consumer DNA-testing market_www.cnbc.com
2020: AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection
2020: Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
2020: DNA Script Expands Series B to $89M
2020: Funding will support commercial launch of SYNTAX™ the world’s first enzymatic DNA printer
2020: INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine
2021: Catalent Has Acquired Delphi Genetics and Launches US Plasmid Site_Plasmid DNA
2021: DNA Origami to Trap Viruses Inside Body
2021: DnaNudge Raises $60M in Series A Funding
2021: Integrated DNA Technologies Acquires Swift Biosciences
2021: New Software Helps Design DNA Nanorobots
2021: Swift Biosciences Bought By DNA Technologies
2021: Synthetic DNA player Touchlight scores $60M round to more than triple manufacturing capacity as mRNA gets hot
2021: TwinStrand Biosciences raises $50M to increase adoption of DNA sequencing tech for cancer detection
2022: NIMH_New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)
23andMe’s Personal Genome Service® enables individuals to explore their own DNA and currently provides more than 200 health and traits reports as well as genetic ancestry information.
A method of amplifying DNA, PCR multiplies a single, microscopic
A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes.
A protective measure that minimizes the probability that a cell will replicate damaged DNA
Affordable DNA-based diagnostics platform, enabling community solutions for public health and biotech education.
Alcyone announced a collaboration with DNAtrix to investigate potential use of Alcyone’s microcatheter system for delivering DNAtrix’s anti-cancer agents directly to brain tumors.
Allows DNA sequence to be read by machine
Andreas Sundquist, co-founder and CEO, Palo Alto, CA-based DNANexus
Applied Biosystems (#1 Market Leader-DNA sequencing)
Applies machine learning to DNA library to predict and optimize novel small molecule modulators for challenging drug targets.
As each new DNA base is added to a growing strand,
Atrin Pharmaceuticals is a private biopharmaceutical company pioneering the discovery & development of proprietary molecules targeting DNA Damage and Response (DDR) pathways to treat a broad spectrum of cancers
Attaches different color flourescent dye to each of the 4 chemical units of DNA
Automated DNA Sequencer
BASF spinoff whose technology lets users label multiple dye molecules on DNA strands in a sequence-specific manner
BioAutomation MM-12 and one MM-48 DNA synthesizers
Biodegradable microspheres; Serve as depots for DNA for gene therapy
Biomarker discovery utilizing novel DNA/RNA amplification technology
biotechnology company, based in Orange County, CA, specializing in the development and commercialization of DNA-based diagnostic
Bring costs so low that it would be feasible to decode an individual's DNA for medical reasons
Brion C. Smith, Col USA (Ret.) DDS, DOD Defense DNA Registry
Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges.
Chair, NIH Recombinant DNA Advisory Committee
Challenging CalTech patent for automated DNA sequencing (2006)
Chemical synthesis platform using DNA-programmed chemistry for the rapid discovery of chemical compounds and reactions
Chronix said its serum DNA biomarkers are applicable to a wide range of cancers and other chronic diseases.
Clinical-stage diagnostic company focused on non-invasive prenatal DNA diagnostic tests for gene translocations, aneuploidy, single genes and Down Syndrome
Codex DNA (NASDAQ: DNAY)
Collecting and analyzing detailed DNA profiles on as many as 100,000 patients
Columbia University licenses next-generation DNA sequencing technology
Common method of creating copies of specific fragments of DNA.
Company Advancing CancerSEEK, A DNA- and Protein-based Liquid Biopsy Test Developed by The Vogelstein Lab at Johns Hopkins University
Company announced a technology collaboration with Google Inc. to provide access to the most comprehensive archive of publicly available DNA data through a hosted Sequence Read Archive (SRA) site.
Company is developing disease-specific biomarkers based on DNA fragments that are released into the bloodstream by damaged and d
Complete Genomics' high quality, affordable DNA sequencing enables commercial-scale research of the genetic mechanisms underlyin
Delfi’s technology uses an approach called cell-free DNA fragmentation, or “fragmentomics,” which is related to the way DNA interacts with nucleosomes and is organized in the chromosomes.
Demonstrate feasibility of building data management system for DNA microarray study data with integrated computational analysis
Develop a faster, cheaper, and potentially more accurate way to identify substances that can damage DNA
Developed a novel in vitro assay to identify chemicals that can damage the DNA of mammalian cells
Developed new multi-reactor biosensor for detection of DNA.
developer of rapid human DNA identification technology and DNA sequencing library preparation systems
Developing a proprietary electroporation delivery technology that is intended to make cancer cells more vulnerable to chemotherapeutic or novel DNA-based immunotherapeutics.
Developing instruments for high-speed sequencing of DNA or RNA without amplification
Developing next-generation desktop DNA sequencing technology that will compartmentalize the entire DNA sequencing process
Developing the next generation cell-free DNA-based noninvasive prenatal test (NIPT) solutions
Development of molecular diagnostic products for diagnosis of critical care infections and developed a DNA macro chip
Development stage dna sequencing company focused on nanopore arrays that can do not require amplification or labeling, closed a $10M Series C financing.
Develops novel cancer therapeutic products that combine its proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics.
Develops solutions to current problems in DNA cloning, sequencing, amplification, and protein expression
DNA & Protein arrays
DNA coated gold particles that deliver drugs to treat influenza and other viral diseases
DNA data management and analysis platform, DNANexus
DNA Database
DNA denatured.
DNA Direct
DNA Direct
DNA Genotek
DNA methylation
DNA microarray technology, in combination with statistical and predictive modeling tools, could be used to evaluate thousands of
DNA molecular diagnostics company
DNA Nanocages-Building addressable Nanoparticle based Architectures for Sensitive Biosensing-Arizona State University (AzTE)
DNA nanotube liquid crystals for NMR structure determination-Harvard University Office of Technology Development
DNA Repair pathway tissue-based biomarkers for drug response prediction in breast and lung cancer
DNA Script
DNA sequencer has revolutionized genomics by allowing the rapid automated sequencing of DNA
DNA sequencing company
DNA Software
DNA Spotter
DNA-based pharmaceuticals for human disease
DNA-based vaccine technology
DNA-Catalyzed Syntheses of Chain-Length and Sequence Specific Synthetic Polymers-Emory University
DNA/RNA
DNA/RNA capture & Analysis
DNANexus
DNAnexus Inc Secures 15 Million Series B Funding Led by Google Inc. Ventures and TPG Biotech (2011)
DnaNudge
DnaNudge apecializes in DNA testing.
DnaNudge leverages consumers’ own DNA plus lifestyle factors to nudge people towards healthier choices while shopping.
DNAR
DNAStar
DNAtriX Inc
Each time the correct base is added to the fragments of DNA, a flash of 10,000 photons is picked up by the light-detecting chip
Electrochemistry for the detection and readout of genetic variations in DNA or RNA
Electroporation is a method that uses electrical pulses to create temporary pores in cell membranes, potentially allowing efficient uptake of a DNA-based vaccine or other substance.
Encapsulate DNA
Encodia’s protein sequencing approach uses reverse-translation technology that turns peptide sequences into DNA, which can then be read by a DNA sequencer
EpiCheck uses next-generation sequencing to identify changes in DNA methylation that indicate the onset of cancer, then applies PCR techniques to translate those findings into scalable lab tests.
Epigenetics -- the study of how to switch genes on and off without affecting the underlying DNA sequence
Every Patient will give a DNA sample
Finance & Acquisitions: DNANexus
Finance & Acquisitions: DNAtriX
Flashes from more than a million DNA-containing wells, arrayed on a credit-card-sized plate, are monitored by a light-detecting
Foundation’s technology platform uses high-throughput DNA sequencing to analyze cancerous tissues for alterations in more than 200 genes.
Gene therapy vector design will be improved by incorporating cell type specific DNA sequences that increase nuclear import,
Gene-encoded therapeutics company developing non-viral DNA and RNA gene delivery platforms for COVID-19 and rare diseases, with broad potential for application in enhancing antibody-centric therapeutics
Graduates include Madison's Exact Sciences, which is developing a non-invasive DNA test for detecting colon cancer.
Has developed a “digital PCR” method to quantify small amounts of DNA for gene expression analysis and other applications
Has developed a platform that it calls Sequencing by Expansion (SBX), a rapid nanopore DNA sequencing technology that can generate results in 60 minutes with only 15 minutes of hands-on time.
High capacity DNA storage systems
High-speed DNA sequencing instruments, which are high-tech machines that can determine the order of the nucleotide bases--adenin
His inventions include the automated DNA sequencer, a device to create proteins and an automated tool for synthesizing DNA.
holds the license for a DNA-based Influenza vaccine candidate developed at the University of Massachusetts
IBS is developing a next generation DNA sequencing system that aims to simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 1,000.
Ichor develops clinical applications and commercialization of electroporation technology for the delivery of DNA drugs and vaccines to treat and prevent debilitating or life threatening diseases.
Ichor Medical Systems’ TriGrid™ Delivery System (TriGrid) is the first integrated and fully automated device for electroporation-mediated DNA administration in humans.
Ichor, a privately held biotech company based in San Diego, CA, is collaborating with partners to provide its enabling TriGrid platform as a means for delivery of DNA drugs and vaccines in disease indications such as cancer, malaria, hepatitis B virus (HBV
IM injections of DNA encoding glutamic acid decarboxylase (GAD) could suppress diabetes in an animal model
ImmunoGenetix Therapeutics is a biotech company that is developing powerful therapeutic DNA vaccines that serve to actively induce a potent physiological immune response against and for the treatment of infectious diseases
improve the method of intramuscular (IM) DNA vaccination
Improving DNA Vaccination for Insulin Dependent Diabetes Mellitus -NMTB
In 2006, Dr. Federoff was named Chair of the NIH Recombinant DNA Advisory Committee.
Indication of enthusiasm for epigenetics, an emerging field of science that looks at how certain genes can be turned on or off without altering the underlying DNA.
Infectious Myonecrosis Virus (IMNV) Nucleotide Sequence, Primers for RT-PCR and a DNA Probe for In Situ Hybridization Assays for Detection of the Virus in Shrimp-University of Arizona
Isilon provides the immense data storage capability that biologists need when they run DNA sequencers that spit out billions of data points.
It's based on so-called "junk DNA" — bits of genetic code found in human cells that previously were thought useless and are now
Its solutions include the Rosetta Resolver Expression Data Analysis System, FlexJet DNA microarray technology, and coherent data sets of information.
Kill tumor cells by targeting molecules involved in cell growth, avoiding the damage to DNA that conventional chemotherapy cause
Lab901 develops and manufactures electrophoresis products for DNA, RNA, and protein research
LaserGen is a Houston-based biotechnology company commercializing a next-generation DNA sequencing chemistry.
LavaAmp, a portable, inexpensive thermal cycler, in order to perform DNA tests for infectious diseases in low resource environme
Life makes the Personal Genome Machine and Ion Proton DNA sequencers
Machine for decoding DNA
Machine's limitation can only read DNA fragments 100 units in length, compared with 800-units attainable by Sanger-based machine
Maker of automated DNA and RNA diagnostics testing systems
Medco project, DNA from more than 1,000 patients’ blood samples will be shipped to the Mayo Clinic,
Methods for differential diagnosis of DNA microarray studies
most likely methylation of DNA within regulatory regions.
New way of packing DNA onto specially fabricated arrays with unprecedented density.
New`DNA strands synthesized
NHGRI funds development of third generation DNA sequencing technologies, September 14, 2010 News Release
Organization & Developments: DNANexus
Organization & Developments: DNAtriX
Partnership between the founding team at Mohr Davidow Ventures who seeded the venture to explore ways of expanding the use of next generation DNA sequencing platforms in molecular diagnostics.
Patent-pending assays using synthetic DNA and functional conjugate molecules (Oligofluors) in a handheld reader system
PCR rapidly amplifies a single DNA molecule into many billions of molecules.
Pioneered 4 instruments--DNA gene sequence/synthesizer & protein synthesizer/sequencer--which form techn foundation of contempor
Pleasanton, CA-based QuantaLife, which has developed a “digital PCR” method to quantify small amounts of DNA for gene expression analysis and other applications, said that it has collected $17.2 million in Series B financing. The round was led by Series A
Previous work conducted by U.S. Genomics included development of products to sequence DNA, in addition to its work to develop biosensors and diagnostics for pathogens, which it had deployed through government agencies.
Products help scientists make use of data from dna sequencing instruments.
Propose development of methods for manipulating cells in culture without the need for DNA transfer
Provides products for molecular biology including buffers, RNA/DNA reagents, & cell biology laboratory including traditional cel
PT-112 has a pleiotropic mechanism of action that is not subject to DNA damage repair pathways and promotes immune cell infiltration into the tumor microenvironment.
Quick and cost-effective system for the detection of pathogens, DNA and biomarkers in the health care, food safety and bio-terrorism industries
Rather than cloning DNA to produce numerous copies, its machine reads a single strand by using lasers, a camera, and tiny fluore
Razor focused on rare mitochondrial DNA depletion disorders
Recombinant DNA Advisory Committee, NIH
Safe synthetic polymeric gene delivery system with high transfection efficiency for local delivery of plasmid DNA
Salmonella Anti-Influenza DNA and Antigen Delivery Vaccine-Arizona State University (AzTE)
sample-to-answer products for DNA-based human identity testing and forensics, next generation sequencing, biodefense, and molecular diagnostics applications.
Scanning DNA of thousands of individuals
Scientists take an existing enzyme, or stretch of DNA to make an enzyme, and tweak properties here and there to get a useful pro
Sells DNA & RNA testing systems for screening, monitoring & diagnosis of disease
Singlera has proprietary technologies in single cell sequencing, DNA methylation, and bioinformatics.
Singlera's circulating tumor DNA (ctDNA) methylation multi-cancer screening technology PanSeer®
software to analyze DNA & RNA, small molecules & proteins
Statistical methods for analysis of DNA microarray data
Strategic Goal 1:Software ID for DNA Fingerprints
Synthetic biology, in which biological materials such as DNA and genes are created from scratch
that have been shown to enhance transfection relative to naked DNA.
The chemists knew in each cycle which of the four DNA bases they had added, a flash of light indicated the sequence at that poin
The company analyzes millions of unique genetic variations in DNA samples
The company has a way to continuously record the sequence of individual DNA molecules
The company has created a DNA data management and analysis platform that provides instant online genomics data centers for researchers and sequencing service providers
The company has developed and patented core technology for circulating cell-free DNA NGS analysis.
The company is developing a directed approach to cell-free DNA (cfDNA) analysis in maternal blood to create a safe, highly accurate and affordable test for pregnant women.
The Company possesses two proprietary technologies: Repeat Sequence Deplete DNA probes (ReSeD), and Hybridization in Suspension
The company's primary product family includes more than 100 real-time PCR assay panels designed for high-performance analysis of DNA, RNA, epigenetic and microRNA targets in biological pathways associated both with specific diseases such as cancer, diabete
The company’s in-market and pipeline products, based on its novel, patented MultiCode® platform chemistry, are the next generation of DNA- and RNA-based testing for the early detection of infectious diseases and genetic conditions.
The DNA Marketplace
The partnership is expected to aid researchers and pharmaceutical companies to conduct DNA sequencing of pathogens and human tissue, as they relate to human infectious diseases.
The patent covers the use of two AAV vectors to deliver DNA sequences that, once inside a cell, are used to produce a single pro
The RapidHIT 200 will allow DNA analysis at the point of collection, such as an arrest or detention, setting a new standard in the usage of DNA profiles as an actionable biometric.
The result is a simple blood or urine test that can detect cancer based on miniscule changes in a person’s DNA, allowing for much earlier diagnoses and less invasive methods than other tissue-based tests.
The system utilizes Optical Mapping Technology to generate ordered, whole genome genetic maps from single DNA molecules.
The technique depends on separating the double helix of DNA into single strands,
This enzyme is a key factor in bacterial DNA repair and the development of antibiotic resistance.
Tick-Borne Encephalitis DNA Vaccines (RIID 96-10)
To fund its modular DNA control systems, Intrexon closed another round of Series D financing, enlisting the help of 65 investors in the process.
Together with DNA (gene) array technique, tissue microarray technology is a powerful tool for the rapid analysis of molecular ta
Touchlight DNA Services
Transgenomic is a global company with a core biotechnology business that includes principal technologies for DNA/RNA and protein analysis and separations.
Trevigen is a rapidly growing biotechnology company focused on the development of technologies pertaining to apoptosis, DNA damage and repair, and genetic variability analysis
Triple Helix DNA, Inc
Turn your smartphone into a convenient, low-cost lab for quick DNA diagnostics and on-site disease tracking
Twist was founded by Emily Leproust and Bill Peck, who each had worked on DNA synthesis technology at Agilent Technologies, and Bill Banyai
UK DNA Banking Network & British biobank
Unlike competing DNA sequencing companies that are instrument sellers, Complete Genomics hopes to do the sequencing itself and s
Uses DNA gene silencing to attack a gene that helps tumor cells survive.
Uses the chemistry of fireflies to generate a flash of light each time a unit of DNA is correctly analyzed
Using its novel technology platform of cationic lipids and non-coding DNA complexes.
Using the TLR technology, vaccines can be produced by simple, low-cost, highly-scalable recombinant DNA techniques, avoiding man
Will study a particular group of DNA motifs — genetic combinations of letters that repeat more frequently than expected by chance — called "pyknons," which Rigoutsos discovered in 2005.
wo major programs anchor the Company's research platform : DNA/RNA-based Medicines and Small Molecules.
ZS Genetics is developing a technology platform for directly creating detailed images of individual DNA or RNA molecules.